Name | Role | Date | Shares | Price | Value |
---|---|---|---|---|---|
James C. Momtazee | Director | 2025-09-10 | 3,282 | $13.77 | $45.19kSell |
Melissa B. Epperly | Director | 2025-09-10 | 1,661 | $13.77 | $22.87kSell |
Meghan Fitzgerald | Director | 2025-09-10 | 937 | $13.77 | $12.90kSell |
Ilan Oren | Director | 2025-09-10 | 2,043 | $13.77 | $28.13kSell |
Daniel Allen Gold | Director | 2025-09-10 | 5,270 | $13.77 | $72.57kSell |
Vivek Ramaswamy | 10% Owner | 2025-09-05 | 385,816 | $12.96 | $5.00MSell |
Vivek Ramaswamy | 10% Owner | 2025-09-04 | 194,933 | $12.92 | $2.52MSell |
Vivek Ramaswamy | 10% Owner | 2025-09-03 | 1,195,000 | $12.50 | $14.94MSell |
Richard Pulik | CFO | 2025-08-28 | 2,340 | $11.94 | $27.94kSell |
Eric Venker | President Immunovant CEO | 2025-08-20 | 100,000 | $3.85 | $385.00kBuy |
Name | Hold | Shares | Value | Type |
---|---|---|---|---|
Qvt Financial LP | 17.50% | 119,488,624 | $1.67B | Insider |
Daniel Allen Gold | 16.48% | 112,554,034 | $1.57B | Insider |
Dexcel Pharma Technologies Ltd | 15.06% | 102,849,443 | $1.43B | Insider |
Keith S. Manchester | 11.33% | 77,387,972 | $1.08B | Insider |
Svf Investments Uk Ltd | 10.69% | 73,031,667 | $1.02B | Insider |
Sumitomo Chemical Co Ltd | 10.43% | 71,251,083 | $993.95M | Insider |
Sb Investment Advisers Uk Ltd | 8.78% | 59,952,652 | $836.34M | Institution |
Fmr LLC | 8.13% | 55,509,281 | $774.35M | Institution |
Vivek Ramaswamy | 7.16% | 48,866,216 | $681.68M | Insider |
Morgan Stanley | 6.54% | 44,693,966 | $623.48M | Institution |